American Journal of Cardiology
Volume 101, Issue 8, Supplement , Pages S9-S13, 17 April 2008

The Safety of Niacin in the US Food and Drug Administration Adverse Event Reporting Database

  • Alawi A. Alsheikh-Ali, MD
    • ,
  • Richard H. Karas, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Richard H. Karas, MD, PhD, Molecular Cardiology Research Institute, Box #80, Tufts-New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111.

Institute for Clinical Research and Health Policy Studies and Molecular Cardiology Research Institute, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)00251-8

doi:10.1016/j.amjcard.2008.02.027

American Journal of Cardiology
Volume 101, Issue 8, Supplement , Pages S9-S13, 17 April 2008

Article Tools

* Image Usage & Resolution